Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses
Open Access
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 27 (11) , 1892-1905
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
This publication has 49 references indexed in Scilit:
- Eradication of Liver-Implanted Tumors by Semliki Forest Virus Expressing IL-12 Requires Efficient Long-Term Immune ResponsesThe Journal of Immunology, 2013
- Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12Molecular Therapy, 2012
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune EscapeCancer Research, 2012
- A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumorsGene Therapy, 2011
- Development of a Liver-specific Tet-On Inducible System for AAV Vectors and Its Application in the Treatment of Liver CancerMolecular Therapy, 2011
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in miceCancer Immunology, Immunotherapy, 2011
- Alphavirus vectors for cancer therapyVirus Research, 2010
- Semliki Forest Virus Expressing Interleukin-12 Induces Antiviral and Antitumoral Responses in Woodchucks with Chronic Viral Hepatitis and Hepatocellular CarcinomaJournal of Virology, 2009
- Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signalNature Immunology, 2009
- Seroprevalence of Measles Antibody in the US Population, 1999–2004The Journal of Infectious Diseases, 2007